SCHEMBL845686

SCHEMBL845686

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3cccnc3Cl)cc2)cc1)[C@@H]1CCCN1C(=O)c1ccccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.43
SMO Q99835 1/20 0.43
HTT P42858 1/20 0.43
RHOC P08134 1/20 0.43
RHOA P61586 1/20 0.43
MAPT P10636 4/20 0.42
ALDH1A1 P00352 2/20 0.42
MALT1 Q9UDY8 1/20 0.42
RAB9A P51151 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
DGAT1 O75907 1/20 0.42
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ITGB1 P05556 2/20 0.41
ITGA4 P13612 2/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845708 0.95 RHOC (0.46) HTTRHOCRHOAMAPTALDH1A1
SCHEMBL844980 0.84 ALDH1A1 (0.45) HTTRHOCRHOAMAPTALDH1A1
SCHEMBL845710 0.81 KMT2A (0.43) HSD11B1HTTMAPTALDH1A1RAB9A
SCHEMBL845059 0.81 ALDH1A1 (0.46) HTTALDH1A1TRPV1DGAT1CYP2C9
SCHEMBL845048 0.80 DGAT1 (0.50) HTTRHOCRHOAMAPTALDH1A1
SCHEMBL845008 0.80 ALDH1A1 (0.54) HTTMAPTALDH1A1CYP2C9CYP2C19
SCHEMBL845651 0.80 CYP2C9 (0.43) HTTRHOCRHOAALDH1A1TRPV1
SCHEMBL845301 0.80 PABPC1 (0.51) HTTALDH1A1TRPV1CYP2C9CYP2C19
SCHEMBL845350 0.79 MAPK1 (0.49) HTTALDH1A1TRPV1CYP2C9CYP2C19
SCHEMBL845704 0.79 TRPV1 (0.48) HTTALDH1A1TRPV1DGAT1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed